Literature DB >> 26917677

The efficacy and safety of posterior scleral reinforcement using genipin cross-linked sclera for macular detachment and retinoschisis in highly myopic eyes.

Shuang-Qian Zhu1, Lin-Yan Zheng1, An-Peng Pan1, A-Yong Yu1, Qin-Mei Wang1, An-Quan Xue1.   

Abstract

BACKGROUND/AIMS: To evaluate the efficacy and safety of posterior scleral reinforcement (PSR) using genipin cross-linked sclera as the material to treat macular detachment and retinoschisis, both without macular hole, in highly myopic eyes.
METHODS: Twenty-one patients with highly myopic eyes (24 eyes) with macular detachment and retinoschisis were treated sequentially with genipin cross-linked PSR and were followed for at least 1 year after surgery. The best-corrected visual acuity (BCVA), spherical equivalent (SE) power, axial length (AL), optical coherence tomography, and the complications were evaluated.
RESULTS: The mean SE decreased from -13.81±4.67 D preoperatively to -9.64±4.86 D postoperatively, while the improvement in the logMAR BCVA values was from 1.24±0.57 before surgery to 1.03±0.57 after surgery. The preoperative AL (29.73±2.31 mm) was decreased (28.08±2.08 mm) after the operation. The retina in 21 eyes (87.5%) was successful reattached and the macular detachment was significantly decreased in two eyes; a macular hole occurred in one eye.
CONCLUSIONS: For at least a 1 year period of follow-up, PSR with genipin cross-linked sclera was safe and effective to treat macular detachment and retinoschisis in high myopia when a macular hole was not present. The reinforcement effect tended to be stabilised and maintained for 6 months after treatment. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Macula; Retina; Treatment Surgery

Mesh:

Substances:

Year:  2016        PMID: 26917677     DOI: 10.1136/bjophthalmol-2015-308087

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  8 in total

1.  Genipin inhibits the scleral expression of miR-29 and MMP2 and promotes COL1A1 expression in myopic eyes of guinea pigs.

Authors:  Min Wang; Zhi-Kuan Yang; Hong Liu; Rui-Qin Li; Yu Liu; Wen-Jun Zhong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-03-03       Impact factor: 3.117

2.  Posterior scleral contraction to treat myopic traction maculopathy at different stages.

Authors:  Shuangqian Zhu; Anquan Xue; Haoyu Li; Jie Ye; Anpeng Pan; Jingwei Zheng; Guoxu Xu
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

3.  Posterior scleral reinforcement for the treatment of myopic traction maculopathy.

Authors:  Qing He; Xiu Wang; Qianhui Shi; Caiyuan Xie; Anquan Xue; Ruihua Wei
Journal:  BMC Ophthalmol       Date:  2022-06-21       Impact factor: 2.086

4.  Biomechanical Considerations of Patching Material for Posterior Scleral Reinforcement Surgery.

Authors:  Jinlei Ma; Fangyuan Wu; Zhiyong Liu; Yijiong Fang; Xu Chu; Linyan Zheng; Anquan Xue; Kaihui Nan; Jia Qu; Lingyun Cheng
Journal:  Front Med (Lausanne)       Date:  2022-05-16

5.  Scleral Cross-Linking in Form-Deprivation Myopic Guinea Pig Eyes Leads to Glaucomatous Changes.

Authors:  Lei Guo; Rui Hua; Xinxin Zhang; Ting Yu Yan; Yang Tong; Xin Zhao; Shi Chao Chen; Moying Wang; Neil M Bressler; Jun Kong
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-05-02       Impact factor: 4.925

6.  Clinical Investigation of the Posterior scleral contraction to Treat Macular Traction Maculopathy in Highly Myopic Eyes.

Authors:  An-Peng Pan; Ting Wan; Shuang-Qian Zhu; Liang Dong; An-Quan Xue
Journal:  Sci Rep       Date:  2017-02-21       Impact factor: 4.379

7.  Comparison of macular buckling and vitrectomy for the treatment of macular schisis and associated macular detachment in high myopia: a randomized clinical trial.

Authors:  Bingqian Liu; Shida Chen; Yonghao Li; Ping Lian; Xiujuan Zhao; Xiling Yu; Tao Li; Chenjin Jin; Xiaoling Liang; Suber S Huang; Lin Lu
Journal:  Acta Ophthalmol       Date:  2019-11-17       Impact factor: 3.761

8.  Genipin Cross-Linked Decellularized Nucleus Pulposus Hydrogel-Like Cell Delivery System Induces Differentiation of ADSCs and Retards Intervertebral Disc Degeneration.

Authors:  Lei Yu; Yi Liu; Jianxin Wu; Shuang Wang; Jiangming Yu; Weiheng Wang; Xiaojian Ye
Journal:  Front Bioeng Biotechnol       Date:  2021-12-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.